Ongoing
Closed
Pharmacological inhibition of glyoxalase-1 (Glo-1) as a new therapeutic strategy to enhance the antitumor effect of trabectedin in preclinical models of soft tissue sarcoma
Fri Dec 1, 2017
Effects of new molecular target therapies for renal carcinoma on bone tumor microenvironment
Mon 1nd Jun, 2017
Effects of cyclin-dependent kinase inhibitors (CDK4/6) on pre-clinical models of bone metastases from breast cancer
Sun Jan 1, 2017
